12/5
07:00 am
inmb
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
Low
Report
Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
12/1
08:52 am
inmb
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595's Evidence Base in High-Inflammation Alzheimer's Patients [Yahoo! Finance]
High
Report
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595's Evidence Base in High-Inflammation Alzheimer's Patients [Yahoo! Finance]
12/1
08:00 am
inmb
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
High
Report
INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer's Patients
11/18
08:00 am
inmb
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
Low
Report
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
11/9
01:13 am
inmb
Medium
Report
10/30
04:12 pm
inmb
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update [Yahoo! Finance]
Low
Report
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update [Yahoo! Finance]
10/30
04:05 pm
inmb
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
Medium
Report
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
10/23
07:00 am
inmb
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
Neutral
Report
INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
10/14
07:20 am
inmb
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025 [Yahoo! Finance]
Low
Report
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025 [Yahoo! Finance]
10/14
07:00 am
inmb
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
Low
Report
INmune Bio to Participate in Dermatologic Rare Disease Panel at the Maxim Growth Summit 2025
9/29
08:16 am
inmb
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer's Disease to npj Dementia, a Nature Portfolio Journal [Yahoo! Finance]
Low
Report
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer's Disease to npj Dementia, a Nature Portfolio Journal [Yahoo! Finance]
9/29
08:00 am
inmb
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
Low
Report
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
9/15
08:21 am
inmb
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult [Yahoo! Finance]
Low
Report
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult [Yahoo! Finance]
9/15
08:00 am
inmb
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
Medium
Report
INmune Bio Announces Successful Completion of First Commercial Pilot-Scale Manufacturing Run of CORDStrom™ at CGT Catapult
9/8
06:41 pm
inmb
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]
Low
Report
INmune Bio (INMB) Loses 23.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner [Yahoo! Finance]